Antischistosomal Activity of Trioxaquines: In Vivo Efficacy and Mechanism of Action on Schistosoma mansoni
暂无分享,去创建一个
J. Boissier | B. Meunier | B. Gourbal | V. Collière | Julien Portela | A. Robert | V. Pradines | Frédéric Coslédan
[1] Yves Moné,et al. An example of molecular co-evolution: reactive oxygen species (ROS) and ROS scavenger levels in Schistosoma mansoni/Biomphalaria glabrata interactions. , 2011, International journal for parasitology.
[2] J. Boissier,et al. Trioxaquine PA1259 Alkylates Heme in the Blood-Feeding Parasite Schistosoma mansoni , 2011, Antimicrobial Agents and Chemotherapy.
[3] N. Baddour,et al. Miltefosine, a promising novel agent for schistosomiasis mansoni. , 2011, International journal for parasitology.
[4] J. Keiser,et al. Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo. , 2011, Experimental parasitology.
[5] E. Reisinger,et al. Schistosoma mansoni: schistosomicidal effect of mefloquine and primaquine in vitro. , 2011, Experimental parasitology.
[6] M. Tanner,et al. ACTs for schistosomiasis: do they act? , 2010, The Lancet. Infectious diseases.
[7] B. Meunier,et al. Heme as trigger and target for trioxane-containing antimalarial drugs. , 2010, Accounts of chemical research.
[8] S. Xiao,et al. Further observation on histopathological alterations of adult Schistosoma japonicum harbored in mice following treatment with mefloquine at a smaller single dose , 2010, Parasitology Research.
[9] J. Utzinger,et al. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] J. Keiser,et al. Praziquantel analogs with activity against juvenile Schistosoma mansoni. , 2010, Bioorganic & medicinal chemistry letters.
[11] S. Xiao,et al. Transmission electron microscopic observation on ultrastructural alterations in Schistosoma japonicum caused by mefloquine , 2010, Parasitology Research.
[12] J. Keiser,et al. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni , 2009, Parasitology.
[13] A. Jadhav,et al. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. , 2009, Journal of medicinal chemistry.
[14] J. Boissier,et al. In Vitro Activities of Trioxaquines against Schistosoma mansoni , 2009, Antimicrobial Agents and Chemotherapy.
[15] T. Egan,et al. Interference with Hemozoin Formation Represents an Important Mechanism of Schistosomicidal Action of Antimalarial Quinoline Methanols , 2009, PLoS neglected tropical diseases.
[16] Conor R. Caffrey,et al. Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening , 2009, PLoS neglected tropical diseases.
[17] Sandra D. Melman,et al. Towards an understanding of the mechanism of action of praziquantel. , 2009, Molecular and biochemical parasitology.
[18] M. Tanner,et al. Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice , 2009, PLoS neglected tropical diseases.
[19] M. Tanner,et al. Effect of single-dose oral artemether and tribendimidine on the tegument of adult Clonorchis sinensis in rats , 2009, Parasitology Research.
[20] B. Mordmüller,et al. Selection of a trioxaquine as an antimalarial drug candidate , 2008, Proceedings of the National Academy of Sciences.
[21] Jozef Vercruysse,et al. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. , 2008, Travel medicine and infectious disease.
[22] B. Meunier,et al. The Antimalarial Trioxaquine DU1301 Alkylates Heme in Malaria-Infected Mice , 2008, Antimicrobial Agents and Chemotherapy.
[23] John M. Pisciotta,et al. Hemozoin: oil versus water. , 2008, Parasitology international.
[24] B. Meunier,et al. Hybrid molecules with a dual mode of action: dream or reality? , 2008, Accounts of chemical research.
[25] Anton Simeonov,et al. Identification of oxadiazoles as new drug leads for the control of schistosomiasis , 2008, Nature Medicine.
[26] S. Laurent,et al. Synthesis of "Trioxaquantel" ® Derivatives as Potential New Antischistosomal Drugs , 2008 .
[27] J. Keiser,et al. Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. , 2008, Experimental parasitology.
[28] D. McManus,et al. Pumping iron: a potential target for novel therapeutics against schistosomes , 2007, Trends in parasitology.
[29] J. Lelièvre,et al. Trioxaquines and Heme-Artemisinin Adducts Inhibit the In Vitro Formation of Hemozoin Better than Chloroquine , 2007, Antimicrobial Agents and Chemotherapy.
[30] Tony J Collins,et al. ImageJ for microscopy. , 2007, BioTechniques.
[31] R. Fetter,et al. Proteomic analysis of adult S. mansoni gut contents. , 2007, Molecular and biochemical parasitology.
[32] M. Tanner,et al. In Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome Species , 2007, Antimicrobial Agents and Chemotherapy.
[33] J. Lelièvre,et al. Trioxaquines Are New Antimalarial Agents Active on All Erythrocytic Forms, Including Gametocytes , 2007, Antimicrobial Agents and Chemotherapy.
[34] D. McManus,et al. Tracking the fate of iron in early development of human blood flukes , 2007, The international journal of biochemistry & cell biology.
[35] P. Sobhon,et al. Schistosoma mekongi: the in vitro effect of praziquantel and artesunate on the adult fluke. , 2006, Experimental parasitology.
[36] Elke Hacker,et al. Two Isoforms of a Divalent Metal Transporter (DMT1) in Schistosoma mansoni Suggest a Surface-associated Pathway for Iron Absorption in Schistosomes* , 2006, Journal of Biological Chemistry.
[37] E. Hempelmann,et al. Structural and morphological characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus , 2005, FEBS letters.
[38] B. Meunier,et al. The antimalarial drug artemisinin alkylates heme in infected mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Laurent,et al. C10-modified artemisinin derivatives: efficient heme-alkylating agents. , 2005, Angewandte Chemie.
[40] D. Cioli,et al. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. , 2004, International journal for parasitology.
[41] Shun-ke Zhang,et al. Schistosoma japonicum: isolation and identification of peptides mimicking ferritin epitopes from phage display library. , 2004, Acta biochimica et biophysica Sinica.
[42] D. McManus,et al. The ultrastructural architecture of the adult Schistosoma japonicum tegument. , 2003, International journal for parasitology.
[43] T. Wellems. Plasmodium Chloroquine Resistance and the Search for a Replacement Antimalarial Drug , 2002, Science.
[44] M. Tanner,et al. Ultrastructural alterations in adult Schistosoma mansoni caused by artemether. , 2002, Memorias do Instituto Oswaldo Cruz.
[45] B. Meunier,et al. From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. , 2002, Accounts of chemical research.
[46] S. D. de Vlas,et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence , 2001, Tropical medicine & international health : TM & IH.
[47] J. Boissier,et al. Male-female larval interactions in Schistosoma mansoni-infected Biomphalaria glabrata. , 2001, International journal for parasitology.
[48] M. Tanner,et al. Artemether administered together with haemin damages schistosomes in vitro. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[49] A. Ruppel,et al. [Studies on the activity and immunohistochemistry of heme oxygenase in Schistosoma japonicum]. , 2001, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.
[50] B. Meunier,et al. Preparation and Antimalarial Activities of “Trioxaquines”, New Modular Molecules with a Trioxane Skeleton Linked to a 4‐Aminoquinoline , 2000, Chembiochem : a European journal of chemical biology.
[51] F. Rumjanek,et al. Haemozoin in Schistosoma mansoni. , 2000, Molecular and biochemical parasitology.
[52] M. Tanner,et al. Tegumental changes in adult Schistosoma mansoni harboured in mice treated with praziquantel enantiomers. , 2000, Acta tropica.
[53] J. Karle,et al. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. , 1999, Journal of medicinal chemistry.
[54] T. Day,et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. , 1999, The American journal of tropical medicine and hygiene.
[55] B. Meunier,et al. Alkylating Properties of Antimalarial Artemisinin Derivatives and Synthetic Trioxanes when Activated by a Reduced Heme Model , 1998 .
[56] P. Fallon,et al. Praziquantel: an urgent and exciting challenge. , 1996, Parasitology today.
[57] P. Schüssler,et al. An isoform of ferritin as a component of protein yolk platelets in Schistosoma mansoni , 1995, Molecular reproduction and development.
[58] W. Kunz,et al. Ferritins of Schistosoma mansoni: sequence comparison and expression in female and male worms. , 1992, Molecular and biochemical parasitology.
[59] C. Le,et al. Schistosoma mansoni: effect of transferrin and growth factors on development of schistosomula in vitro. , 1989 .
[60] L. E. Clemens,et al. Schistosoma mansoni: effect of transferrin and growth factors on development of schistosomula in vitro. , 1989, The Journal of parasitology.
[61] R. Wilson,et al. Synthesis of macromolecules by the epithelial surfaces of Schistosoma mansoni: an autoradiographic study , 1979, Parasitology.
[62] F. Cox. Death of a schistosome , 1979, Nature.
[63] P. W. Pappas,et al. Membrane transport in helminth parasites: a review. , 1975, Experimental parasitology.